Back

Lipoprotein (a), coronary artery disease risk, and MACE in individuals without standard modifiable risk factors in the UK Biobank

31 August 2024 (12:30 - 12:45)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Preventive Cardiology Secondary Prevention ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jason Sangha

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Long-term weight change in midlife, cardiac magnetic resonance parameters, risk of atrial fibrillation: a large prospective cohort study
Mr J. Li (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention
Doctor M. Hansen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Bidirectional relationship between kidney disease progression and cardiovascular events in type 2 diabetes: new Insights from the CANVAS Program and CREDENCE trial
Doctor B. Neuen (Sydney, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Young Investigator Award Session in Preventive Cardiology
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 12:30 CET
You may be interested in
thumbnail
Congress Session
Controversies in lipoprotein(a)
thumbnail
Congress Presentation
Lp(a) epidemiology and pathophysiology
thumbnail
Congress Presentation
Prevalence of elevated lipoprotein(a) in premature ASCVD patients and its association with major adverse cardiovascular events: analysis of a large US electronic health record database

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources